117 related articles for article (PubMed ID: 38234834)
1. Discovery of genomic and transcriptomic pleiotropy between kidney function and soluble receptor for advanced glycation end-products using correlated meta-analyses: The Long Life Family Study (LLFS).
Feitosa MF; Lin SJ; Acharya S; Thyagarajan B; Wojczynski MK; Kuipers AL; Kulminski A; Christensen K; Zmuda JM; Brent MR; Province MA
medRxiv; 2023 Dec; ():. PubMed ID: 38234834
[TBL] [Abstract][Full Text] [Related]
2. Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study.
Rebholz CM; Astor BC; Grams ME; Halushka MK; Lazo M; Hoogeveen RC; Ballantyne CM; Coresh J; Selvin E
Nephrol Dial Transplant; 2015 Jan; 30(1):77-83. PubMed ID: 25147225
[TBL] [Abstract][Full Text] [Related]
3. An Integrative Genomic Strategy Identifies sRAGE as a Causal and Protective Biomarker of Lung Function.
Keefe J; Yao C; Hwang SJ; Courchesne P; Lee GY; Dupuis J; Mizgerd JP; O'Connor G; Washko GR; Cho MH; Silverman EK; Levy D
Chest; 2022 Jan; 161(1):76-84. PubMed ID: 34237330
[TBL] [Abstract][Full Text] [Related]
4. Relationships between vitreous levels of soluble receptor for advanced glycation end products (sRAGE) and renal function in patients with diabetic retinopathy.
Katagiri M; Shoji J; Kato S; Kitano S; Uchigata Y
Int Ophthalmol; 2017 Dec; 37(6):1247-1255. PubMed ID: 27830398
[TBL] [Abstract][Full Text] [Related]
5. Genome-Wide Association Study of Renal Function Traits: Results from the Japan Multi-Institutional Collaborative Cohort Study.
Hishida A; Nakatochi M; Akiyama M; Kamatani Y; Nishiyama T; Ito H; Oze I; Nishida Y; Hara M; Takashima N; Turin TC; Watanabe M; Suzuki S; Ibusuki R; Shimoshikiryo I; Nakamura Y; Mikami H; Ikezaki H; Furusyo N; Kuriki K; Endoh K; Koyama T; Matsui D; Uemura H; Arisawa K; Sasakabe T; Okada R; Kawai S; Naito M; Momozawa Y; Kubo M; Wakai K;
Am J Nephrol; 2018; 47(5):304-316. PubMed ID: 29779033
[TBL] [Abstract][Full Text] [Related]
6. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide association analysis of cystatin-C kidney function in continental Africa.
Mayanja R; Machipisa T; Soremekun O; Kamiza AB; Kintu C; Kalungi A; Kalyesubula R; Sande OJ; Jjingo D; Fabian J; Robinson-Cohen C; Franceschini N; Nitsch D; Nyirenda M; Zeggini E; Morris AP; Chikowore T; Fatumo S
EBioMedicine; 2023 Sep; 95():104775. PubMed ID: 37639939
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome- and proteome-wide association studies nominate determinants of kidney function and damage.
Schlosser P; Zhang J; Liu H; Surapaneni AL; Rhee EP; Arking DE; Yu B; Boerwinkle E; Welling PA; Chatterjee N; Susztak K; Coresh J; Grams ME
Genome Biol; 2023 Jun; 24(1):150. PubMed ID: 37365616
[TBL] [Abstract][Full Text] [Related]
9. AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease.
Molinari P; Caldiroli L; Dozio E; Rigolini R; Giubbilini P; Romanelli MMC; Messa P; Vettoretti S
Antioxidants (Basel); 2021 Dec; 10(12):. PubMed ID: 34943097
[TBL] [Abstract][Full Text] [Related]
10. GWAS meta-analysis of kidney function traits in Japanese populations.
Hishida A; Nakatochi M; Sutoh Y; Nakano S; Momozawa Y; Narita A; Tanno K; Shimizu A; Hozawa A; Kinoshita K; Yamaji T; Goto A; Noda M; Sawada N; Ikezaki H; Nagayoshi M; Hara M; Suzuki S; Koyama T; Koriyama C; Katsuura-Kamano S; Kadota A; Kuriki K; Yamamoto M; Sasaki M; Iwasaki M; Matsuo K; Wakai K
J Epidemiol; 2024 Apr; ():. PubMed ID: 38583947
[TBL] [Abstract][Full Text] [Related]
11. Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD).
Leonardis D; Basta G; Mallamaci F; Cutrupi S; Pizzini P; Tripepi R; Tripepi G; De Caterina R; Zoccali C
Nutr Metab Cardiovasc Dis; 2012 Sep; 22(9):748-55. PubMed ID: 21470837
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association study of the risk of chronic kidney disease and kidney-related traits in the Japanese population: J-Kidney-Biobank.
Sugawara Y; Hirakawa Y; Nagasu H; Narita A; Katayama A; Wada J; Shimizu M; Wada T; Kitamura H; Nakano T; Yokoi H; Yanagita M; Goto S; Narita I; Koshiba S; Tamiya G; Nangaku M; Yamamoto M; Kashihara N
J Hum Genet; 2023 Feb; 68(2):55-64. PubMed ID: 36404353
[TBL] [Abstract][Full Text] [Related]
13. Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients.
Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Ueda Y; Suzuki T; Yamada S; Takeuchi M; Fukami K; Ueda S; Adachi H; Matsui T; Okuda S; Yamagishi S
Metabolism; 2009 Nov; 58(11):1624-8. PubMed ID: 19604520
[TBL] [Abstract][Full Text] [Related]
14. TWAS revealed significant causal loci for milk production and its composition in Murrah buffaloes.
Chhotaray S; Vohra V; Uttam V; Santhosh A; Saxena P; Gahlyan RK; Gowane G
Sci Rep; 2023 Dec; 13(1):22401. PubMed ID: 38104199
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants in the receptor for advanced glycation end products (RAGE) gene were associated with circulating soluble RAGE level but not with renal function among Asians with type 2 diabetes: a genome-wide association study.
Lim SC; Dorajoo R; Zhang X; Wang L; Ang SF; Tan CSH; Yeoh LY; Ng XW; Li N; Su C; Liu S; Wong MDS; Low KMS; Yao AO; Babitha J; Fun S; Zhou S; Lee SBM; Tang WE; Tavintharan S; Sum CF; Liu JJ
Nephrol Dial Transplant; 2017 Oct; 32(10):1697-1704. PubMed ID: 27448675
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease.
Sandholm N; Cole JB; Nair V; Sheng X; Liu H; Ahlqvist E; van Zuydam N; Dahlström EH; Fermin D; Smyth LJ; Salem RM; Forsblom C; Valo E; Harjutsalo V; Brennan EP; McKay GJ; Andrews D; Doyle R; Looker HC; Nelson RG; Palmer C; McKnight AJ; Godson C; Maxwell AP; Groop L; McCarthy MI; Kretzler M; Susztak K; Hirschhorn JN; Florez JC; Groop PH;
Diabetologia; 2022 Sep; 65(9):1495-1509. PubMed ID: 35763030
[TBL] [Abstract][Full Text] [Related]
17. How powerful are summary-based methods for identifying expression-trait associations under different genetic architectures?
Veturi Y; Ritchie MD
Pac Symp Biocomput; 2018; 23():228-239. PubMed ID: 29218884
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Pleiotropic Genes and Therapeutic Targets Associated with Heart Failure and Chronic Kidney Disease by Integrating metaCCA and SGLT2 Inhibitors' Target Prediction.
Li H; Mai Z; Yu S; Wang B; Lai W; Chen G; Zhou C; Liu J; Yang Y; Chen S; Liu Y; Chen J
Biomed Res Int; 2021; 2021():4229194. PubMed ID: 34540994
[TBL] [Abstract][Full Text] [Related]
19. Four missense genetic variants in
Uglebjerg N; Ahmadizar F; Aly DM; Cañadas-Garre M; Hill C; Naber A; Oddsson A; Singh SS; Smyth L; Trégouët DA; Chaker L; Ghanbari M; Steinthorsdottir V; Ahlqvist E; Hadjadj S; Van Hoek M; Kavousi M; McKnight AJ; Sijbrands EJ; Stefansson K; Simons M; Rossing P; Ahluwalia TS
Front Endocrinol (Lausanne); 2023; 14():1081741. PubMed ID: 36926036
[TBL] [Abstract][Full Text] [Related]
20. Integrating eQTL and GWAS data characterises established and identifies novel migraine risk loci.
Ghaffar A; ; Nyholt DR
Hum Genet; 2023 Aug; 142(8):1113-1137. PubMed ID: 37245199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
